Related Experiment Video
Updated: Feb 6, 2026
QTL Mapping and CRISPR/Cas9 Editing to Identify a Drug Resistance Gene in Toxoplasma gondii
Published on: June 22, 2017
DNA vaccine ROP29 from Toxoplasma gondii containing R848 enhances protective immunity in mice
Gang Lu1, Jian Zhou2,3, Ying Hui Zhao1
1Institute of Pathogen Biology, Taishan Medical College, Taian, Shandong, China.
Aims:
Toxoplasma gondii is an intracellular parasite that causes a global epidemic parasitic disease. Studies using DNA vaccines for the control of toxoplasmosis have made considerable progress. ROP proteins were proven to be excellent candidates for T. gondii DNA vaccine development.
Methods And Results:
Here, a ROP29 DNA vaccine was successfully produced and injected into mice in combination with R848 to evaluate its ability to provide protection against T. gondii challenge. Compared with other mice, the mice injected with R848/pROP29 produced higher levels of IgG, IgG2a, interleukin (IL)-12, and interferon gamma (IFN-γ). Moreover, after a challenge of 20 T. gondii cysts, the number of brain cysts was lower in the R848/pROP29-immunized mice than in the other experimental mice.
Conclusions:
R848 could improve the productions of IL-12 and IFN-γ, thus enhancing the immune responses stimulated by the pROP29 DNA vaccine.
Related Concept Videos
01:51Vaccinations
01:38What is the Immune System?
01:36Humoral Immune Responses
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
03:00Self-Evaluation: Self-Enhancement and Self-Verification
02:31Protection of Alcohols
Protection
It defines a protecting group as the masking agent to make the more reactive species inert to a given set of conditions. This concept is depicted via the illustration of liquid flow through different outlets in an assembly of pipes. The analogy helps to understand the role...